Last updated on September 2018

UCB Transplant for Hematological Diseases Using a Non Myeloablative Prep


Brief description of study

This is a phase II trial using a non-myeloablative cyclophosphamide/ fludarabine/total body irradiation (TBI) preparative regimen with modifications based on factors including diagnosis, disease status, and prior treatment. Single or double unit selected according to current University of Minnesota umbilical cord blood graft selection algorithm.

Clinical Study Identifier: NCT02722668

Find a site near you

Start Over